Articles in neonatology

https://youtu.be/617nU8k015g?si=-7RtstHkbvNORet_

https://fb.me/e/5HaQHl6MJ?sfnsn=scwspmo

Back to webinar activity First live Journal club in Tarek's Neonatology on Monday the 19th of January 2026 16:00 UK time with Dr Tim van Hasselt we will discuss this article: This paper is open access, it has epidemiology including some stats to discuss, and looks at the quality of life of adults born preterm which is I think will be of interest. The Impact of Prematurity on Self-Reported Quality of Life in Adulthood: A Prospective Swedish National Cohort of Infants Born with Extremely Low Birth Weight - ScienceDirect https://www.sciencedirect.com/science/article/pii/S0022347625004974?via%3Dihub Book your free ticket here : Free Free Free https://www.eventbrite.co.uk/e/journal-club-tickets-1980321853974?utm-campaign=social&utm-content=attendeeshare&utm-medium=discovery&utm-term=listing&utm-source=cp&aff=ebdsshcopyurl objectives : we will learn together How to choose an article ... the good ones Summary of the paper Statistical term and techniques Critical appraisal Be ready by your questions

We are going to discuss this article tomorrow at 4 pm UK time as a live journal clubits free to join

The Impact of Prematurity on Self-Reported Quality of Life in Adulthood: A Prospective Swedish National Cohort Study of Infants Born with Extremely Low Birth Weight

An Explainable Machine Learning Model for Predicting Necrotizing Enterocolitis in Neonates Based on Complete Blood Count Parameters

A simple scoring system for prediction of IVH in very-low-birth- weight infants Praveen Kumar1✉ and Mounika Polavarapu2 © The Author(s), under exclusive licence to the International Pediatric Research Foundation, Inc 2023

https://www.instagram.com/stories/kotbtarek/3763292991155345008?utm_source=ig_story_item_share&igsh=MWRjMGZpdWtvczR4cw==

https://www.linkedin.com/posts/tarek-kotb-b5988a46_neonatology-pediatrics-cardiology-activity-7392169898237612032-5_vz?utm_source=social_share_send&utm_medium=android_app&rcm=ACoAAAm9kfUB5wquMEn1IfrwamVq4iCJOX-zj-0&utm_campaign=share_via

Reintubation rates after extubation to different non-invasive ventilation modes in preterm infants

🌟 Master the Essentials of Neonatal Cardiology – Live Webinar 📅 November 15, 2025 | 🕔 5:00–8:00 PM GMT | 💻 Microsoft Teams Are you a junior neonatologist, pediatrician, NICU nurse, MRCPCH candidate, or medical student eager to strengthen your understanding of congenital heart disease in newborns? Join us for an exclusive interactive webinar — “Essentials of Neonatal Cardiology: From Diagnosis to Initial Management.” 🩺 Key Takeaways: ✅ Identify clinical signs of critical CHD in newborns ✅ Interpret essential diagnostics (saturations, ECG, echo views) ✅ Initiate stabilization and management of duct-dependent lesions ✅ Differentiate cardiac vs. respiratory causes of neonatal distress 👨‍⚕️ Speaker: Dr. Tarek Kotb – sharing real-world neonatal cardiology expertise. 📍 Register here: 👉 https://www.eventbrite.co.uk/e/the-essentials-of-neonatal-cardiology-tickets-1917510267829 💡 Use code Tareksneonatology for 20% off! 🎯 Limited seats – secure yours today! #Neonatology #Pediatrics #Cardiology #CHD #NeonatalCare #MedicalEducation #HealthcareProfessionals #MRCPCH #NICU #ContinuousLearning #Webinar #ClinicalSkills #TareksNeonatology

https://www.facebook.com/groups/3240998489457821/posts/5068095666748085/

Intravenous midazolam infusion for sedation of infants in the neonatal intensive care unit. BACKGROUND: Proper sedation for neonates undergoing uncomfortable procedures may reduce stress and avoid complications. Midazolam is a short-acting benzodiazepine that is used increasingly in neonatal intensive care units (NICUs). However, its effectiveness as a sedative in neonates has not been systematically evaluated. OBJECTIVES: Primary objeciveTo assess the effectiveness of intravenous midazolam infusion for sedation, as evaluated by behavioural and/or physiological measurements of sedation levels, in critically ill neonates in the NICU. Secondary objectives To assess effects of intravenous midazolam infusion for sedation on complications including the following. 1. Incidence of intraventricular haemorrhage (IVH)/periventricular leukomalacia (PVL) 2. Mortality. 3. Occurrence of adverse effects associated with the use of midazolam (hypotension, neurological abnormalities). 4. Days of ventilation. 5. Days of supplemental oxygen. 6. Incidence of pneumothorax. 7. Length of NICU stay (days). 8. Long-term neurodevelopmental outcomes. SELECTION CRITERIA: We selected for review randomised and quasi-randomised controlled trials of intravenous midazolam infusion for sedation in infants aged 28 days or younger. DATA COLLECTION AND ANALYSIS: We abstracted data regarding the primary outcome of level of sedation. We assessed secondary outcomes such as intraventricular haemorrhage, periventricular leukomalacia, death, length of NICU stay and adverse effects associated with midazolam. When appropriate, we performed meta-analyses using risk ratios (RRs) and risk differences (RDs), and if the RD was statistically significant, we calculated the number needed to treat for an additional beneficial outcome (NNTB) or an additional harmful outcome (NNTH), along with their 95% confidence intervals (95% CIs) for categorical variables, and weighted mean differences (WMDs) for continuous variables. We assessed heterogeneity by performing the I-squared (12) test. MAIN RESULTS: We included in the review three trials enrolling 148 neonates. We identified no new trials for this update. Using different sedation scales, each study showed a statistically significantly higher sedation level in the midazolam group compared with the placebo group. However, none of the sedation scales used have been validated in preterm infants; therefore, we could not ascertain the effectiveness of midazolam in this population Duration of NICU stay was significantly longer in the midazolam group than in the placebo group (WMD 5.4 days, 95% CI 0.40 to 10.5; 12 = 0%; two studies, 89 infants). One study (43 infants) reported significantly lower Premature Infant Pain Profile (PIPP) scores during midazolam infusion than during dextrose (placebo) infusion (MD -3.80, 95% CI -5.93 to -1.67). Another study (46 infants) observed a higher incidence of adverse neurological events at 28 days' postnatal age (death, grade III or IV IVH or PVL) in the midazolam group compared with the morphine group (RR 7.64, 95% CI 1.02 to 57.21; RD 0.28, 95% CI 0.07 to 0.49; NNTH 4, 95% CI 2 to 14) (tests for heterogeneity not applicable). We considered these trials to be of moderate quality according to GRADE assessment based on the following outcomes: mortality during hospital stay, length of NICU stay, adequacy of analgesia according to PIPP scores and poor neurological outcomes by 28 days' postnatal age. AUTHORS' CONCLUSIONS: Data are insufficient to promote the use of intravenous midazolam infusion as a sedative for neonates undergoing intensive care. This review raises concerns about the safety of midazolam in neonates. Further research on the effectiveness and safety of midazolam in neonates is needed.

Intravenous midazolam infusion for sedation of infants in the neonatal intensive care unit (Review)

Improving outcomes for very preterm babies in England: does place of birth matter? Findings from OPTI- PREM, a national cohort study

Assessment of enteral nutrition in preterm infants with patent ductus Assessment of enteral nutrition in preterm infants with patent ductus arteriosus undergoing medical treatment

Paediatric cranial ultrasound: assessment of the preterm brain Caoilfhionn Ní Leidhin1,2* , Michael Paddock3,4,5, Paul M. Parizel6,7, Richard R. Warne1,2, Peter Shipman1,2 and Rahul Lakshmanan1,2,8*

Congenital Long QT Syndrome Type 2 with Symptomatic 2:1 Atrioventricular Block and Ventricular Arrhythmia in a Preterm Baby Who Presented with Fetal Ventricular Tachycardia and Hydrops

Perinatal Risk Factors and Lung Function at 8 Years of Age in Extremely Preterm Infants: Insights from a New Japanese Bronchopulmonary Dysplasia Classification

What CPAP to use in the delivery room? Bench comparison of two methods to provide continuous positive airways pressure in neonates